An alternative pathway of reverse cholesterol transport: The oxysterol 27-hydroxycholesterol

Atherosclerosis

Volumn 209, Issue 1, 2010, Pages 39-41

  Weingärtner, Oliver ^a   Laufs, Ulrich ^a   Böhm, Michael ^a   Lütjohann, Dieter ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Atherosclerosis; HDL cholesterol; Oxysterols; Reverse cholesterol transport

Indexed keywords

26 HYDROXYCHOLESTEROL; ACETYLSALICYLIC ACID; CHOLESTEROL; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OXYSTEROL; STEROL 27 HYDROXYLASE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CHOLESTEROL TRANSPORT; DISEASE SEVERITY; EMERGENCY WARD; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UPREGULATION;

ADULT; BIOLOGICAL TRANSPORT; CHOLESTEROL; CORONARY DISEASE; CYTOCHROME P-450 CYP27A1; HUMANS; HYDROXYCHOLESTEROLS; LIPOPROTEINS, HDL; MALE; MYOCARDIAL INFARCTION; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 77249090669     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.015     Document Type: Article

References (13)

1. Björkhelm I., Andersson O., Diczfalusy U., et al. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci USA 91 (1994) 8592-8596
2. Reiss A.B., Martin K.O., Javitt N.B., et al. Sterol 27-hydroxylase: high level activity in vascular endothelium. J Lipid Res 35 (1994) 1026-1030
3. Lütjohann D., Bjorkhem I., Beil U.F., and von Bergmann K. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J Lipid Res 36 (1995) 1763-1773
4. Thelen K.M., Rentsch K.M., Gutteck U., et al. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J Pharmacol Exp Ther 316 (2006) 1146-1152
5. Miettinen T.A., Tilvis R.S., and Kesaniemi Y.A. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131 (1990) 20-31
6. Turley SD, Dietschy JM. The metabolism and excretion of cholesterol by the liver. In: Biology and pathobiology. 2nd edition. New York: Raven Press, Ltd., 1988. pp. 617-641.
7. Pieters M.N., Schouten D., and Berkel T.J.V. In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim Biophys Acta 11 (1994) 125-134
8. Barter P.J., Caulfield M., Eriksson M., et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357 21 (2007) 2109-2122
9. van der Steeg W.A., Holme I., Boekholdt S.M., et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J Am Col Cardiol 51 6 (2008) 634-642
10. Babiker A., Dzeletovic S., Wiklund B., et al. Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid. Scand J Clin Lab Invest 65 (2005) 365-375
11. Lund E., Andersson O., Zhang J., et al. Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler Thromb Vasc Biol 16 (1996) 208-212
12. Björkhelm I., and Muri-Boberg K. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Sciver C., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic basis of inherited diseases (1994), Mc Graw Hill, New York, NY 2073-2100
13. von Bahr S., Movin T., Papadogiannakis N., et al. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1). Arterioscler Thromb Vasc Biol 22 (2002) 1129-1135